Navigation Links
VaxGen Issues Rebuttal to MedCap Letter
Date:3/25/2008

Analyst at Punk Ziegel and Co.; and Dr. George Schreiner, the Raven CEO. These references, which are abbreviated and taken out of context, also potentially mislead our stockholders in an attempt to encourage them to vote against the proposed merger.

In the case of Dr. Seiler, MedCap neglected to point out that in her recent report (dated March 18, 2008 and subtitled "We endorse the merger and remain cautiously optimistic regarding the vote"), she encourages stockholders to support the proposed merger and further states: "We think a shareholder vote to reject the merger with Raven would represent a fairly disastrous outcome for VaxGen and would view it as a clear signal to sell VaxGen shares". Instead, MedCap chose to reference only a fraction of a quotation from Dr. Seiler's recent report, thus changing the meaning entirely. Dr. Seiler's full quote is provided in the addendum to this letter.

In the case of Dr. Schreiner, MedCap misquotes him in an attempt to imply that Raven's goal to eventually find a development partner for its lead clinical candidate (RAV12, now entering a Phase 2 trial) indicates a lack of confidence in this compound. This argument is disingenuous at best. Any sophisticated investor in biotechnology companies is aware that they routinely partner their programs with pharmaceutical companies to reduce the risk and expense associated with extensive and costly late stage clinical trials. Indeed, many investors believe that attracting a strong development partner constitutes validation of the underlying scientific program.

MedCap continues this pattern of selective quotation in a further release dated March 20, 2008 entitled: "ISS recommends vote against VaxGen proposals -- Applauded by MedCap". MedCap states that it "agrees entirely with the newly published [ISS] recommendations." If that is the case, then it should be noted that ISS estimates the present value of VaxGen liquidation proceeds to be $0.49 per share. Put simply, t
'/>"/>

SOURCE VaxGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
3. VaxGen Files First Quarter 2007 Financials
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. VaxGen Files Last Outstanding Periodic Report With SEC
6. VaxGen Addresses MPM Claims in Letter to Stockholders
7. VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board
8. VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal
9. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
10. VaxGen to Present at the 10th Annual BIO CEO and Investor Conference
11. VaxGen Reports Financial Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 ... market research report is available ... Whole Exome Sequencing Market by ... Target Enrichment), by Services (Sequencing), ... by Application (Cancer, Monogenic disorders) ...
(Date:8/28/2014)... 2014  Armetheon, Inc. ( www.armetheon.com ), a ... late-stage cardiovascular drug candidates, today announced that it ... of financing. The Series A round was co-led ... participation from investors that included Atheneos Capital and ... Larry Hsu , the founder of Impax Laboratories. ...
(Date:8/28/2014)... 2014 PrimeSource Building Products, Inc., ... SoundConnect to support their communication needs ... and web conferencing platform GlobalMeet powered by SoundConnect. ... needs. SoundConnect delivers award winning “results driven” ... Products will be utilizing GlobalMeet powered by ...
(Date:8/27/2014)... Aug. 27, 2014 Rhythm, a biopharmaceutical company ... deficiencies that result in metabolic disorders, announced today that ... with the U.S. Securities and Exchange Commission (SEC) relating ... its common stock. The number of shares to be ... not yet been determined. Citigroup and Cowen ...
Breaking Biology Technology:Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 2Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 3Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 4Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 5Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 6Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 7Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 8Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 9Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 10Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 11Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 12Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 13Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3PrimeSource Chooses SoundConnect as Collaboration Provider 2Rhythm Files Registration Statement for Proposed Initial Public Offering 2
... significant contract with Major Biopharmaceutical CompanyBELGIUM, Wis., March ... is pleased to announce that its subsidiary, Modular ... MPS BioPharm to better reflect its vision, and ... from a major global biopharmaceutical and consumer health ...
... Berkeley -- As synthetic biologists cram more and ... organisms produce ever more complex drugs and chemicals, ... step further. , They have assembled different types ... can perform functions such as secreting and responding ...
... Alternext US: CXM) today announced the completion of a $3.5 ... warrants to purchase shares of common stock. Empire Asset Management ... the transaction. The material terms of the credit facility ... on Form 8-K to be filed with the Securities and ...
Cached Biology Technology:Mach One Subsidiary Modular Process Constructors LLC Changes Name to MPS BioPharm to Better Reflect its Vision 2Assembling cells into artificial 3-D microtissues, including a tiny gland 2Assembling cells into artificial 3-D microtissues, including a tiny gland 3Cardium Completes $3.5 Million Credit Facility 2Cardium Completes $3.5 Million Credit Facility 3Cardium Completes $3.5 Million Credit Facility 4
(Date:8/29/2014)... connections in transcription factor networks (TFNs) to evaluate the ... in PLOS Computational Biology in August. ... a network,s resilience against mutations. , "In simulations, ... models has a greater effect on robustness than varying ... Dov A. Pechenick, PhD, lead author and former researcher ...
(Date:8/29/2014)... This news release is available in German . ... of chemical signals between organisms is considered the oldest ... social interactions between conspecifics, for example, the sexual attraction ... trigger social responses and to coordinate reproductive behavior in ... at the University of the Algarve in Faro, Portugal, ...
(Date:8/29/2014)... MO. - In a cell,s nucleus, chromosomal DNA ... histones, an amalgam biologists call chromatin. Until about ... nuclear "sidekick," the mere packing material around which ... biologists have developed a greater appreciation for how ... investigators from multiple research institutions studying the sequence ...
Breaking Biology News(10 mins):Assortativity signatures of transcription factor networks contribute to robustness 2Ready for mating at the right time 2Ready for mating at the right time 3'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3
... published research has hinted at the connection between the ... athletic African-American males, which was initially observed in black ... the first sizeable patient series definitively confirms this risk ... cell trait, for which all U.S. African Americans are ...
... (FY) 2013 appropriations bill adopted by the House Labor, ... Subcommittee on July 18th fails short of the needed ... Health (NIH) and will delay efforts to improve the ... protect the nation against new and emerging health threats. ...
... inconspicuously lives in our bodies until it senses that ... the offensive. The fungus, known for causing yeast and other ... in immunocompromised patients. An in vivo study, published in ... between a healthy and an unhealthy host and alter its ...
Cached Biology News:Sickle cell trait can cause sudden cardiac death in black athletes: Why is this controversial? 2Sickle cell trait can cause sudden cardiac death in black athletes: Why is this controversial? 3House funding bill will delay research progress and place new burdens on NIH 2How a common fungus knows when to attack 2
Request Info...
... the 4300 System features Saga GT , ... SagaGT automates electrophoresis, lane finding, location of ... scoring. ,Saga GT is second generation ... was initially developed at the University of ...
... Polynucleotide Kinase (PNK) catalyzes the transfer ... the 5'-hydroxyl of single- and double-stranded ... enzyme also removes the 3'-phosphate from ... 3', 5'-diphosphates to form a 3'-hydroxyl ...
Request Info...
Biology Products: